Yep , i like where this is going.....the revenue is there, just need the right management in place to translate that revenue and the growth opportunities into profit
Normally a good sign when very experienced execs (ex IOOF and Etrade) are comfortable enough to join a penny dreadful
"Following the completion of the Sequoia Financial Group acquisition in early January and the integration of these businesses in to MDS, the company is now focused on building its executive ranks at both Board and management level to drive organic growth across its respective divisions.
Michael Carter has over 25 years’ experience in management and leadership roles with leading ASX listed companies in the financial services sector. He was most recently the Managing Director of Bridges Financial Services Pty Ltd, a subsidiary of ASX-listed IOOF Holdings Ltd, with responsibility for its stockbroking business, national network of financial advisors and over $10 billion in funds under advice.
"The fact that we have been able to attract executives of this calibre is solid endorsement of our growth prospects, and the potential to achieve greater uptake of our products and services with retail and wholesale clients and the broader wealth management advisory network.”
“MDS is now well placed to capitalise on the growth opportunities available to us following the completion of the Sequoia Financial Group acquisition. Attracting executives that have considerable sector experience and a track record of building businesses in the wealth management sector is key to realising this growth.”
- Forums
- ASX - By Stock
- Ann: Director Appointment/Resignation
SEQ
sequoia financial group ltd
Add to My Watchlist
1.43%
!
35.5¢

Yep , i like where this is going.....the revenue is there, just...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
35.5¢ |
Change
0.005(1.43%) |
Mkt cap ! $43.87M |
Open | High | Low | Value | Volume |
35.5¢ | 35.5¢ | 35.0¢ | $37.20K | 105.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 56039 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.5¢ | 19052 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 50325 | 0.350 |
1 | 2944 | 0.340 |
1 | 2982 | 0.335 |
1 | 3000 | 0.330 |
2 | 69535 | 0.315 |
Price($) | Vol. | No. |
---|---|---|
0.355 | 19052 | 2 |
0.360 | 134902 | 2 |
0.365 | 72540 | 3 |
0.370 | 33513 | 2 |
0.375 | 89000 | 3 |
Last trade - 15.00pm 27/06/2025 (20 minute delay) ? |
Featured News
SEQ (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online